This website uses cookies to improve your browsing experience. Please read our Privacy Policy for more information on what information we gather and how it is used.
Early this year, VitaDAO announced a $4.1 million fundraising round, that included strategic members and longevity enthusiasts such as Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO, Balaji Srinivasan, and Joe Betts-LaCroix.
Following our successful fundraise of $4.1 million (check out the Forbes article), a new wave of projects are in the pipeline to be funded. First up in 2023 is Brain Tissue Replacement Therapy with Jean Hebert
Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO
The Longevity field is starting the year strongly with new updated Hallmarks of aging, exactly 10 years after the original paper was published. So time to update your introduction slides with the figure we will see in every presentation for the next
VitaDAO Letter: Year in Review + Interview with VitaDAO Co-initiator, Tyler Golato
What a year it has been! 2022 was a year full of growth, science, and a whole lot of funded longevity research. In the 1.5 years since VitaDAO’s historic Genesis auction, VitaDAO has funded 15+ longevity projects and gathered 9000+ community members
As the end of the year is fast approaching we wanted to look back and appreciate all the effort and hard work of the researchers in the VitaDAO community - from students, postdocs and fellows to principal investigators
A multitude of discoveries and inventions throughout history have been made by people who were initially trained in one domain, but were able to make a significant contribution to a different field due to their ability to look at a problem with a uni
VitaDAO Letter: New collab with Research Hub, Symposium Recap & more
Inside:
A Recap of VitaDAO’s 2nd “Crypto meets Longevity Symposium” VitaDAO Fellowship Update
New VitaSpotlight Series: Rapamycin as a Promising Aging Intervention How to contribute to VitaDAO and ResearchHub’s Community Driven Paper
Meet DAO Membe
Rapamycin is the most promising aging intervention we currently have
It was in 1975 when scientists from Ayerst (now Pfizer) discovered a novel compound called rapamycin (also known as Sirolimus) in bacteria on Rapa Nui(Easter Island) in Chile. In 1999 rapamycin obtained FDA approval for the prevention of acute reject
Some species in the animal kingdom live extraordinarily long lives. They seem to be somehow protected from all the damage that we would expect to accumulate in aged tissues. Many are very large, like bowhead whales, and there is an established correl
VitaDAO Letter: VitaDAO's first cell therapy funding: ApoptoSENS!
Happy DeSci Fall! Inside this month’s newsletter:
VitaDAO’s 5th IP-NFT Funding Ceremony A New Publication on Decentralized Technology Transfer
The Longevity Decentralized Review Explainer
Meet DAO Member: Estèfano Pinilla
Welcome back to our monthly newsletter! This month we are excited to bring you an interview with Dr. Marco Demaria who has made some significant contributions to our understanding of cellular senescence.
Dear Vitalians, We are glad you are here! Inside this month’s newsletter:
Pfizer, L1 Digital and Shine Capital Contribution Proposals
Passed VitaDAO Proposals Meet DAO Member: Hamza Qureshi
Upcoming Events, including a 2nd VitaDAO Crypto meets Long
We can all agree that the age-associated decline in physiological functionality and increased risk of developing diseases is terrible, but what can we do to treat, slow down or even prevent it?
Dear Vitalians, happy DeSci-Summer!
Inside this month’s newsletter:
Longevity Prize in collaboration with Foresight and Methuselah Foundation
Multichain Voting VitaDAO’s Fourth IP-NFT Ceremony
Upcoming Events
June was a month of celebration for VitaDAO! This June, VitaDAO celebrated its first birthday, held a ceremony for the transfer of VitaDAO's third IP-NFT, and completed another Gitcoin Grant Round.
They say April showers bring May flowers. Instead of flowers, we hope we rose to the occasion with June’s newsletter to show how VitaDAO flourished this May.
Hello Vitalians! April Fools might have started the month, but we promise this Newsletter is no joke! Many people in VitaDAO were able to attend ETHAmsterdam for one of the first ever DeSci days, featuring talks about all things DeSci
Hello Vitalians! Another month, another newsletter- and we couldn’t be more excited about it. Many of the core contributors to the DAO were able to meet up in sunny ☀️ Lisbon this month to organize, bond, and brainstorm in person.
We know we say it every month, but the VitaDAO community has been busy. We’ve been told to shorten these newsletters, but in all honesty, all that happened in VitaDAO this month makes that difficult!
If you have been following the longevity field for even just a little a while, you have probably heard of NAD+… a lot. So what is NAD+, and why are people excited about it?
FRENS: A Generalizable Legal Framework for Fractionalized IP-NFTs
The current drug development system reflects an incentive structure that is anti-competitive and neglects the potential to repurpose existing therapies.
In this January edition of the VitaDAO Newsletter, you can learn about VitaDAO proposals that passed over the last month, get to know DAO rockstar Alex Dobrin, and more!
The VitaDAO community has been hard at work this year pioneering the future of longevity research and IP-NFTs. These past few weeks have been particularly exciting! In this December edition of the VitaDAO Newsletter you will find updates on what has
This article will guide you through the process of using Uniswap to obtain VITA, VitaDAO’s token. For more information on VitaDAO itself, see this blog post as well as further links at the bottom of this article.
.png)
.png)
